Pityriasis rosea is linked to a type of herpesvirus, but not the kind that causes cold sores or genital herpes. The viruses associated with this rash are human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7), which are completely different from herpes simplex virus 1 and 2. Nearly everyone is exposed to HHV-6 and HHV-7 during childhood, often without knowing it, and the viruses then remain dormant in the body for life.
The Herpesvirus Connection
The herpesvirus family is large, and the name can be misleading. There are nine known human herpesviruses, and they cause very different conditions. HHV-6 and HHV-7, the ones tied to pityriasis rosea, are best known for causing roseola, the mild fever-and-rash illness that most children get before age two. After that initial infection, the viruses go dormant. Pityriasis rosea appears to happen when these dormant viruses reactivate.
Dermatologists have found HHV-6 and HHV-7 DNA in the rash tissue, blood, and saliva of people with pityriasis rosea. In one study, researchers detected HHV-6 viral DNA in both tissue and blood samples from patients, along with antibody patterns consistent with viral reactivation rather than a new infection. HHV-7 antibodies were present in 100% of patients tested, and those with viral DNA in their blood and skin also showed antibody markers of active infection. While the exact mechanism isn’t fully settled, the weight of evidence supports HHV-6 and HHV-7 reactivation as the trigger.
The key distinction: these viruses cannot cause cold sores or genital herpes. That’s herpes simplex virus, an entirely separate branch of the family. Having pityriasis rosea says nothing about your sexual health history, and the rash is not a sexually transmitted infection.
What Pityriasis Rosea Looks and Feels Like
The rash follows a distinctive pattern that makes it recognizable. It typically starts with a single oval, slightly raised, scaly patch called the “herald patch” or “mother patch.” This initial spot can range from 1 to 10 centimeters across and usually appears on the back, chest, or abdomen. It’s easy to mistake for ringworm or eczema at this stage.
One to two weeks after the herald patch shows up, smaller oval patches begin spreading across the torso. These “daughter patches” are usually 1 to 2 centimeters and arrange themselves along the lines of the ribs, creating a pattern that looks like drooping Christmas tree branches when viewed from behind. The rash generally stays on the trunk and upper arms and legs, rarely spreading to the face or hands. Some people experience mild itching, while others find the itch significant enough to affect sleep.
How Long It Lasts
Pityriasis rosea is a self-limiting condition, meaning it resolves on its own. The full rash typically lasts 6 to 8 weeks. Over 80% of people see complete clearing by 8 weeks, though some cases can linger a few weeks longer. Once it clears, the skin returns to normal, sometimes with temporary lighter or darker spots at the rash sites that fade over the following months.
Recurrence is uncommon. Only 1 to 3% of people experience a second episode. This is likely because the initial episode provides enough immune activity against the reactivated virus to prevent it from doing the same thing again.
Is It Contagious?
Pityriasis rosea is not considered contagious in any practical sense. Since it’s driven by reactivation of viruses already living inside your body (rather than a new infection caught from someone else), you can’t spread the rash through casual contact, sharing towels, or being in close quarters. Household contacts and partners do not need to take precautions. Clusters in families or close groups have been reported very rarely, but there’s no evidence of routine person-to-person transmission.
Treatment Options
Because pityriasis rosea clears on its own, treatment focuses on managing symptoms, particularly itching. Moisturizing creams, gentle skin care, and over-the-counter anti-itch lotions or oral antihistamines are the standard approach. Topical steroid creams can help with more stubborn itching.
Antiviral medication has been studied since the condition involves a herpesvirus. A meta-analysis of clinical trials found that high-dose acyclovir (an antiviral commonly used for herpes simplex) was better than placebo at achieving complete regression of existing lesions by the first week. Individual trials also showed it helped with itching. However, the antiviral did not significantly shorten the overall duration of the rash compared to placebo, and by week four, outcomes were similar whether or not patients received it. In practice, antivirals are sometimes used for severe cases but aren’t routinely recommended for most people.
Pityriasis Rosea During Pregnancy
Pregnancy deserves special mention because pityriasis rosea carries somewhat higher stakes when it occurs in the first trimester. A review of published cases found that unfavorable outcomes (miscarriage, preterm delivery, or low birth weight) occurred more frequently when the rash appeared early in pregnancy, lasted a long time, spread widely across the body, or came with symptoms beyond the skin such as fever or fatigue. In a pooled analysis, the rate of unfavorable outcomes across prior studies was about 40% when these risk factors were present, though a more recent case series found a much lower rate of roughly 11%.
The earlier in pregnancy the rash appears, the higher the risk. A widespread, long-lasting rash accompanied by systemic symptoms like fever is the combination that raises the most concern. Pregnant women who develop pityriasis rosea are typically monitored more closely by their OB-GYN, and treatment in pregnancy usually involves moisturizers and mild topical steroids rather than antivirals.